Skip to main content

Addyi News

FDA Orders Important Safety Labeling Changes for Addyi Regarding Alcohol Consumption

April 11, 2019 – The U.S. Food and Drug Administration today issued a safety labeling change order to Sprout Pharmaceuticals for their drug, Addyi (flibanserin), that requires the company to revise...

FDA Approves Addyi (flibanserin) for Hypoactive Sexual Desire Disorder in Premenopausal Women

August 18, 2015 - The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Addyi patient information at Drugs.com